Clinical trial
A Phase II, Multicentre, Randomised, Placebo-controlled, Doublemasked Trial of RP101 Ophthalmic Formulation Versus Vehicle in Post-menopausal Women With Moderate to Severe Dry Eye Syndrome
NCT03821415 is registered in ClinicalTrials.gov with Redwood Pharma AB as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II, Multicentre, Randomised, Placebo-controlled, Doublemasked Trial of RP101 Ophthalmic Formulation Versus Vehicle in Post-menopausal Women With Moderate to Severe Dry Eye Syndrome
- Lead sponsor
- Redwood Pharma AB
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- January 18, 2019
- Completion date
- November 18, 2019
- Enrollment
- 104 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.